Search

everythinglearnresearchcommunity

for

Search:↓

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Nonionic liposomes are the best for delivering genes to skin cells.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Finasteride reduces hair loss and treats BPH without major hormone changes, but may cause sexual dysfunction.

Tcf3 helps cells move and heal wounds by controlling lipocalin 2.

miR-218-5p helps skin and hair growth by targeting SFRP2 and activating a specific signaling pathway.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Shorter daylight increases hair growth in Cashmere goats.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

GLI2 increases follistatin production in human skin cells.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Natural molecules like inositols, resveratrol, vitamins, and omega-3 fatty acids may help manage Polycystic Ovary Syndrome (PCOS), but their effects vary and need more exploration.

Fibromodulin treatment helps reduce scarring and improves wound healing by making it more like fetal healing.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Different hair growth problems are caused by genetic issues or changes in hair growth cycles, and new treatments are being developed.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Immune cells affect hair growth and could lead to new hair loss treatments.

Researchers created a mouse model for Cushing's syndrome to study glucocorticoid excess and potential treatments.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.